The reprogramming factors of human somatic cells are novel targets for human hepatocellular carcinoma therapy

Hepatology

Volumn 50, Issue 6, 2009, Pages 2046-

  Moriguchi, Hisashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

CELL DIFFERENTIATION; CELL STRAIN HEPG2; DRUG EFFICACY; DRUG TARGETING; FIBROBLAST; GENE EXPRESSION; HEPATOMA CELL; HUMAN; LETTER; LIVER CELL; LIVER CELL CARCINOMA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGNOSIS; SOMATIC CELL; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; GENES, MYC; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS;

EID: 73149087928     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23287     Document Type: Letter

References (5)

1. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. HEPATOLOGY 2008; 48: 1528-1539.
2. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008;451:141-146.
3. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009;113:5476-5479.
4. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
5. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun 2009;383:157-162.